EzBiome

Executive Summary

EzBiome is a Houston-based biotechnology company founded in 2018, specializing in microbiome research and diagnostics. The company offers a comprehensive suite of services including cGMP-compliant microbial identification, sequencing, and bioinformatics through its proprietary EzBioCloud platform. By linking microbial communities to chronic diseases with high precision, EzBiome aims to empower microbiome innovation and discovery. Its private status and lack of disclosed funding suggest an early-stage or bootstrapped operation, focusing on providing outsourced microbiome analysis to academic and pharmaceutical clients. The company's service-based model positions it as a key enabler in the growing microbiome diagnostics market, which is expected to expand as precision medicine advances. However, without specific product pipeline or revenue data, the company's near-term growth trajectory is uncertain.

Upcoming Catalysts (preview)

• Q3 2026Major platform upgrade or new service launch on EzBioCloud70% success
• TBDPartnership with a large pharmaceutical or diagnostic company40% success
• Q1 2027Regulatory clearance for a microbiome-based diagnostic test30% success